Posted on

NewView Capital leads $22.3M Series B in Australian telehealth platform Eucalyptus

Telehealth platform Eucalyptus raised a $22.3 million Series B round of funding to build a digital health portfolio for primary care in Australia. NewView Capital led the round with participation […]




Posted on

23andMe raises $82.5 million in new funding

DNA testing technology company 23andMe has raised just shy of $82.5 million in new funding, from an offering of $85 million in total equity shares, according to a new SEC […]